Cargando…
Advances in NKT cell Immunotherapy for Glioblastoma
Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myr...
Autores principales: | Pyaram, Kalyani, Yadav, Viveka Nand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108592/ https://www.ncbi.nlm.nih.gov/pubmed/30147849 http://dx.doi.org/10.4172/1948-5956.1000533 |
Ejemplares similares
-
β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation
por: Berga-Bolaños, Rosa, et al.
Publicado: (2015) -
The Role of NKT Cells in Glioblastoma
por: Brettschneider, Emily E. S., et al.
Publicado: (2021) -
Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022) -
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015) -
Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)